2018
DOI: 10.1002/jcp.27889
|View full text |Cite
|
Sign up to set email alerts
|

The dual role of KCNQ/M channels upon OGD or OGD/R insults in cultured cortical neurons of mice: Timing is crucial in targeting M‐channels against ischemic injuries

Abstract: KCNQ/M potassium channels play a vital role in neuronal excitability; however, it is required to explore their pharmacological modulation on N‐Methyl‐ d‐aspartic acid receptors (NMDARs)‐mediated glutamatergic transmission of neurons upon ischemic insults. In the current study, both presynaptic glutamatergic release and activities of NMDARs were measured by NMDAR‐induced miniature excitatory postsynaptic currents (mEPSCs) in cultured cortical neurons of C57 mice undergoing oxygen and glucose deprivation (OGD) o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 52 publications
(83 reference statements)
0
1
0
Order By: Relevance
“…Increasing SK channel activity by using 1-EBIO (SK channel agonist) increases the effect of Mg 2+ blocking on NMDARs and prevents glutamate-mediated excitotoxic damage ( Allen et al, 2011 ). The use of the HCN blocker ZD7288 and the M channel activator retigabine soon after ischemic damage (within 0–6 h) prevents excessive activation of postsynaptic NMDARs, prevents LTP deficits, and provides neuroprotection against oxygen or glucose deprivation in organotypic hippocampal cultures and in vivo ischemic models ( Boscia et al, 2006 ; He et al, 2014 ; Bierbower et al, 2015 ; Diao et al, 2019 ; Chen et al, 2020 ; Table 2 ). Astrocytes also respond to ischemia to prevent neurotoxicity.…”
Section: Therapeutic Potentials Of Mahp Modulatorsmentioning
confidence: 99%
“…Increasing SK channel activity by using 1-EBIO (SK channel agonist) increases the effect of Mg 2+ blocking on NMDARs and prevents glutamate-mediated excitotoxic damage ( Allen et al, 2011 ). The use of the HCN blocker ZD7288 and the M channel activator retigabine soon after ischemic damage (within 0–6 h) prevents excessive activation of postsynaptic NMDARs, prevents LTP deficits, and provides neuroprotection against oxygen or glucose deprivation in organotypic hippocampal cultures and in vivo ischemic models ( Boscia et al, 2006 ; He et al, 2014 ; Bierbower et al, 2015 ; Diao et al, 2019 ; Chen et al, 2020 ; Table 2 ). Astrocytes also respond to ischemia to prevent neurotoxicity.…”
Section: Therapeutic Potentials Of Mahp Modulatorsmentioning
confidence: 99%